ORM1 antibody

Catalog No. ABIN116567

Product Details anti-ORM1 Antibody

Target: ORM1 (Orosomucoid 1 (ORM1))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This ORM1 antibody is un-conjugated

Application: Western Blotting (WB), Enzyme Immunoassay (EIA)

Specificity: Assay by immunoelectrophoresis resulted in a single precipitin arc against purified and partially purified Alpha-1-Acid Glycoprotein [Human Plasma]. Cross reactivity against Alpha-1-Acid Glycoprotein from other tissues and species may occur but have not been specifically determined.

Purification: Prepared from monospecific antiserum by a delipidation and defibrination.

Immunogen: Alpha-1-Acid Glycoprotein [Human Plasma].

Application Details

Application Notes: Suitable for Immunoblotting (Western or Dot blot), ELISA, Immunoprecipitation and mostimmunological methods requiring high titer and specificity. Recommended Dilutions: This product has been assayed against 1.0 μg of Alpha-1-AcidGlycoprotein [Human Plasma] in a standard sandwich ELISA using Peroxidase conjugatedAffinity Purified anti-Rabbit IgG [H&L] (Goat) and ABTS(2,2'-azino-bis-[3-ethylbenthiazoline-6-sulfonic acid]) as a substrate for 30 minutes atroom temperature. A working dilution of 1: 2,000 to 1: 10,000 of the reconstitutionconcentration is suggested for this product.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Handling

Format: Liquid

Reconstitution: Restore with 2.0 mL of deionized water (or equivalent).

Concentration: 90.0 mg/mL (by Refractometry)

Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2 with 0.01 % sodium azide as preservative.

Preservative: Sodium azide

Precaution of Use: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Dilute only prior to immediate use. Avoid cycles of freezing and thawing.

Storage: -20 °C

Storage Comment: Store vial at -20 °C prior to opening. Centrifuge product if not completely clear after standing at room temperature. For extended storage aliquot contents and freeze at -20 °C or below.

Target Details for ORM1

Target: ORM1 (Orosomucoid 1 (ORM1))

Alternative Name: ORM1 / AGP1 (ORM1 Products)

Synonyms: AGP-A antibody, AGP1 antibody, ORM antibody, AGP antibody, Agpa1 antibody, OMD antibody, Orm antibody, OGCHI antibody, Agp-1 antibody, Agp-2 antibody, Orm-1 antibody, orosomucoid 1 antibody, orosomucoid 1 (ovoglycoprotein) antibody, ORM1 antibody, Orm1 antibody

Background: Alpha 1 Acid Glycoprotein (AGP) is an acute phase plasma protein synthesized by the liver. The protein is believed to regulate the interaction between blood cells and endothelial cells, and together with haptoglobin and C reactive protein, also regulates the extravasation of the cells during infection and inflammation. AGP is a major acute phase reactant, both in human and in rat. In human plasma, AGP (44 kDa) is found at levels of 0.5-1.4 mg/mL. Its concentration in blood plasma is elevated during acute inflammation, such as trauma, malignancies, myocardial infarction, rheumatoid arthritis, bacterial infections, after major surgery, in cases of chronic pain etc, and can be used for the diagnosis of inflammatory conditions.Synonyms: Alpha-1-acid glycoprotein 1, OMD1, Orosomucoid-1

Gene ID: 5004

NCBI Accession: NP_000598

UniProt: P02763

Pathways: Response to Growth Hormone Stimulus